Oral Preexposure Prophylaxis Uptake and Discontinuation in the HIV Vaccine Trials Network 704/HIV Prevention Trials Network 085 Study: Implications for Biomedical Human Immunodeficiency Virus Prevention Trials.
Valeria D CantosMoni NeradilekYunda HuangAlison C RoxbyKevin GillespieAllan C deCampShelly T KarunaSrilatha EdupugantiJorge Gallardo-CartagenaJorge SanchezCarlos Del RioValdilea VelosoMyron S CohenDeborah J DonnellLawrence CoreyColleen F KelleyPublished in: Open forum infectious diseases (2024)
When included as standard of prevention in HVTN 704/085, oral PrEP utilization patterns mirrored those observed in real-life settings. Variable effects of oral PrEP on HIV outcomes in clinical trials may be expected based on regional differences in oral PrEP use.